Frontline Ltd.
Frontline Ltd. (FRO) Financial Performance & Income Statement Overview
Review Frontline Ltd. (FRO) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Frontline Ltd. (FRO) Income Statement & Financial Overview
Review Frontline Ltd. FRO income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $425.64M | $490.32M | $556.03M | $578.40M |
| Cost of Revenue | $228.92M | $338.59M | $339.03M | $355.03M |
| Gross Profit | $196.73M | $151.73M | $217.00M | $223.37M |
| Gross Profit Ratio | $0.46 | $0.31 | $0.39 | $0.39 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.71M | $6.96M | $12.57M | $14.85M |
| Operating Expenses | $67.01M | $6.92M | -$38.92M | $14.85M |
| Total Costs & Expenses | $295.93M | $345.51M | $300.11M | $369.87M |
| Interest Income | $2.91M | $5.05M | $5.33M | $2.23M |
| Interest Expense | $75.13M | $82.44M | $73.38M | $71.38M |
| Depreciation & Amortization | $83.15M | $84.16M | $83.71M | $88.01M |
| EBITDA | $217.28M | $231.85M | $348.34M | $296.54M |
| EBITDA Ratio | $0.51 | $0.47 | $0.63 | $0.51 |
| Operating Income | $129.72M | $144.81M | $255.92M | $208.53M |
| Operating Income Ratio | $0.30 | $0.30 | $0.46 | $0.36 |
| Other Income/Expenses (Net) | -$63.20M | -$79.56M | -$66.80M | -$68.90M |
| Income Before Tax | $66.52M | $65.25M | $189.12M | $181.15M |
| Income Before Tax Ratio | $0.16 | $0.13 | $0.34 | $0.31 |
| Income Tax Expense | -$214000.00 | $4.80M | $1.54M | $1.55M |
| Net Income | $66.73M | $60.46M | $187.57M | $180.82M |
| Net Income Ratio | $0.16 | $0.12 | $0.34 | $0.31 |
| EPS | $0.30 | $0.27 | $0.84 | $0.81 |
| Diluted EPS | $0.30 | $0.27 | $0.84 | $0.81 |
| Weighted Avg Shares Outstanding | $222.62M | $222.62M | $222.62M | $222.62M |
| Weighted Avg Shares Outstanding (Diluted) | $222.62M | $222.62M | $222.62M | $222.62M |
The company's financials show resilient growth, with revenue advancing from $578.40M in Q1 2024 to $425.64M in Q4 2024. Gross profit remained healthy with margins at 46% in Q4 2024 compared to 39% in Q1 2024. Operating income hit $129.72M last quarter, sustaining a consistent 30% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $217.28M. Net income rose to $66.73M, while earnings per share reached $0.30. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan